- ¥26bn
- ¥32bn
- ¥37bn
- 71
- 80
- 65
- 88
Annual balance sheet for GL Sciences, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5,891 | 6,358 | 6,119 | 6,557 | 7,451 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8,402 | 9,198 | 10,344 | 11,671 | 12,747 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 20,399 | 22,973 | 24,829 | 30,039 | 33,351 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10,533 | 12,705 | 14,640 | 17,027 | 17,066 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 33,091 | 38,683 | 42,975 | 51,012 | 55,568 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,292 | 7,806 | 8,754 | 10,314 | 10,608 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 11,699 | 14,797 | 16,172 | 21,121 | 21,925 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 21,392 | 23,886 | 26,803 | 29,890 | 33,643 |
| Total Liabilities & Shareholders' Equity | 33,091 | 38,683 | 42,975 | 51,012 | 55,568 |
| Total Common Shares Outstanding |